🇺🇸 Ifosfamide for Injection in United States

206 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Febrile Neutropenia — 89 reports (43.2%)
  2. Malignant Neoplasm Progression — 19 reports (9.22%)
  3. Disease Progression — 16 reports (7.77%)
  4. Product Use In Unapproved Indication — 15 reports (7.28%)
  5. Respiratory Failure — 13 reports (6.31%)
  6. Encephalopathy — 12 reports (5.83%)
  7. Sepsis — 12 reports (5.83%)
  8. Mucosal Inflammation — 11 reports (5.34%)
  9. Pyrexia — 10 reports (4.85%)
  10. Off Label Use — 9 reports (4.37%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Ifosfamide for Injection approved in United States?

Ifosfamide for Injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Ifosfamide for Injection in United States?

BeBetter Med Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.